751 research outputs found
A surprising method for polarising antiprotons
We propose a method for polarising antiprotons in a storage ring by means of
a polarised positron beam moving parallel to the antiprotons. If the relative
velocity is adjusted to the cross section for spin-flip is
as large as about barn as shown by new QED-calculations of
the triple spin-cross sections. Two possibilities for providing a positron
source with sufficient flux density are presented. A polarised positron beam
with a polarisation of 0.70 and a flux density of approximately /(mm s) appears to be feasible by means of a radioactive C
dc-source. A more involved proposal is the production of polarised positrons by
pair production with circularly polarised photons. It yields a polarisation of
0.76 and requires the injection into a small storage ring. Such polariser
sources can be used at low (100 MeV) as well as at high (1 GeV) energy storage
rings providing a time of about one hour for polarisation build-up of about
antiprotons to a polarisation of about 0.18. A comparison with other
proposals show a gain in the figure-of-merit by a factor of about ten.Comment: 13 pages, 8 figures; v2: minor language and signification corrections
v3: (14 pages, 12 figures) major error, nonapplicable polarisation transfer
cross sections replaced by the mandatory spin-flip cross section
Electron-ion recombination of Si IV forming Si III: Storage-ring measurement and multiconfiguration Dirac-Fock calculations
The electron-ion recombination rate coefficient for Si IV forming Si III was
measured at the heavy-ion storage-ring TSR. The experimental electron-ion
collision energy range of 0-186 eV encompassed the 2p(6) nl n'l' dielectronic
recombination (DR) resonances associated with 3s to nl core excitations, 2s
2p(6) 3s nl n'l' resonances associated with 2s to nl (n=3,4) core excitations,
and 2p(5) 3s nl n'l' resonances associated with 2p to nl (n=3,...,infinity)
core excitations. The experimental DR results are compared with theoretical
calculations using the multiconfiguration Dirac-Fock (MCDF) method for DR via
the 3s to 3p n'l' and 3s to 3d n'l' (both n'=3,...,6) and 2p(5) 3s 3l n'l'
(n'=3,4) capture channels. Finally, the experimental and theoretical plasma DR
rate coefficients for Si IV forming Si III are derived and compared with
previously available results.Comment: 13 pages, 9 figures, 3 tables. Accepted for publication in Physical
Review
Relativistic quantum dynamics in strong fields: Photon emission from heavy, few-electron ions
Recent progress in the study of the photon emission from highly-charged heavy
ions is reviewed. These investigations show that high- ions provide a unique
tool for improving the understanding of the electron-electron and
electron-photon interaction in the presence of strong fields. Apart from the
bound-state transitions, which are accurately described in the framework of
Quantum Electrodynamics, much information has been obtained also from the
radiative capture of (quasi-) free electrons by high- ions. Many features in
the observed spectra hereby confirm the inherently relativistic behavior of
even the simplest compound quantum systems in Nature.Comment: Version 18/11/0
Cell transformation assays for prediction of carcinogenic potential: State of the science and future research needs
Copyright @ 2011 The Authors. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0), which permits
unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Cell transformation assays (CTAs) have long been proposed as in vitro methods for the identification of potential chemical carcinogens. Despite showing good correlation with rodent bioassay data, concerns over the subjective nature of using morphological criteria for identifying transformed cells and a lack of understanding of the mechanistic basis of the assays has limited their acceptance for regulatory purposes. However, recent drivers to find alternative carcinogenicity assessment methodologies, such as the Seventh Amendment to the EU Cosmetics Directive, have fuelled renewed interest in CTAs. Research is currently ongoing to improve the objectivity of the assays, reveal the underlying molecular changes leading to transformation and explore the use of novel cell types. The UK NC3Rs held an international workshop in November 2010 to review the current state of the art in this field and provide directions for future research. This paper outlines the key points highlighted at this meeting
The long noncoding RNA RNCR2 directs mouse retinal cell specification
<p>Abstract</p> <p>Background</p> <p>Recent work has identified that many long mRNA-like noncoding RNAs (lncRNAs) are expressed in the developing nervous system. Despite their abundance, the function of these ncRNAs has remained largely unexplored. We have investigated the highly abundant lncRNA RNCR2 in regulation of mouse retinal cell differentiation.</p> <p>Results</p> <p>We find that the RNCR2 is selectively expressed in a subset of both mitotic progenitors and postmitotic retinal precursor cells. ShRNA-mediated knockdown of RNCR2 results in an increase of both amacrine cells and Müller glia, indicating a role for this lncRNA in regulating retinal cell fate specification. We further report that RNCR2 RNA, which is normally nuclear-retained, can be exported from the nucleus when fused to an IRES-GFP sequence. Overexpression of RNCR2-IRES-GFP phenocopies the effects of shRNA-mediated knockdown of RNCR2, implying that forced mislocalization of RNCR2 induces a dominant-negative phenotype. Finally, we use the IRES-GFP fusion approach to identify specific domains of RNCR2 that are required for repressing both amacrine and Müller glial differentiation.</p> <p>Conclusion</p> <p>These data demonstrate that the lncRNA RNCR2 plays a critical role in regulating mammalian retinal cell fate specification. Furthermore, we present a novel approach for generating dominant-negative constructs of lncRNAs, which may be generally useful in the functional analysis of this class of molecules.</p
Rethinking intelligent behaviour through the lens of accurate prediction: Adaptive control in uncertain environments
While recent cognitive science research shows a renewed interest in understanding intelligence, there is still little consensus on what constitutes intelligent behaviour and how it should be assessed. Here we propose a refined approach to biological intelligence as accurate prediction, according to which intelligent behaviour should be understood as adaptive control driven by the minimisation of uncertainty in dynamic environments with limited information. Central to this view is the concept of accuracy, which we argue is key to determining the success of predictions. We identify tensions in applying this framework to contemporary artificial systems such as large-language models, which, despite their impressive capacities for abstract prediction, show deficits in terms of context-sensitive knowledge transfer
The long noncoding RNA Six3OS acts in trans to regulate retinal development by modulating Six3 activity
Organoiridium complexes : anticancer agents and catalysts
Iridium is a relatively rare precious heavy metal, only slightly less dense than osmium. Researchers have long recognized the catalytic properties of square-planar Ir(I) complexes, such as Crabtree's hydrogenation catalyst, an organometallic complex with cyclooctadiene, phosphane, and pyridine ligands. More recently, chemists have developed half-sandwich pseudo-octahedral pentamethylcyclopentadienyl Ir(III) complexes containing diamine ligands that efficiently catalyze transfer hydrogenation reactions of ketones and aldehydes in water using H2 or formate as the hydrogen source. Although sometimes assumed to be chemically inert, the reactivity of low-spin 5d(6) Ir(III) centers is highly dependent on the set of ligands. Cp* complexes with strong σ-donor C^C-chelating ligands can even stabilize Ir(IV) and catalyze the oxidation of water. In comparison with well developed Ir catalysts, Ir-based pharmaceuticals are still in their infancy. In this Account, we review recent developments in organoiridium complexes as both catalysts and anticancer agents. Initial studies of anticancer activity with organoiridium complexes focused on square-planar Ir(I) complexes because of their structural and electronic similarity to Pt(II) anticancer complexes such as cisplatin. Recently, researchers have studied half-sandwich Ir(III) anticancer complexes. These complexes with the formula [(Cp(x))Ir(L^L')Z](0/n+) (with Cp* or extended Cp* and L^L' = chelated C^N or N^N ligands) have a much greater potency (nanomolar) toward a range of cancer cells (especially leukemia, colon cancer, breast cancer, prostate cancer, and melanoma) than cisplatin. Their mechanism of action may involve both an attack on DNA and a perturbation of the redox status of cells. Some of these complexes can form Ir(III)-hydride complexes using coenzyme NAD(P)H as a source of hydride to catalyze the generation of H2 or the reduction of quinones to semiquinones. Intriguingly, relatively unreactive organoiridium complexes containing an imine as a monodentate ligand have prooxidant activity, which appears to involve catalytic hydride transfer to oxygen and the generation of hydrogen peroxide in cells. In addition, researchers have designed inert Ir(III) complexes as potent kinase inhibitors. Octahedral cyclometalated Ir(III) complexes not only serve as cell imaging agents, but can also inhibit tumor necrosis factor α, promote DNA oxidation, generate singlet oxygen when photoactivated, and exhibit good anticancer activity. Although relatively unexplored, organoiridium chemistry offers unique features that researchers can exploit to generate novel diagnostic agents and drugs with new mechanisms of action
- …
